We are live on ! Find out more
MIM

Marco Investment Management Portfolio holdings

AUM $1.52B
1-Year Est. Return 47.33%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+47.33%
3 Year Est. Return
+126.67%
5 Year Est. Return
+163.42%
10 Year Est. Return
+1,200.89%
AUM
$640M
AUM Growth
+$35M
Cap. Flow
-$10.6M
Cap. Flow %
-1.66%
Top 10 Hldgs %
26.95%
Holding
189
New
14
Increased
70
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.97M
2
MDT icon
Medtronic
MDT
+$4.45M
3
AGN
Allergan plc
AGN
+$4.02M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.62M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$1.55M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
DD
Du Pont De Nemours E I
DD
+$6.73M
3
PYPL icon
PayPal
PYPL
+$2.77M
4
MON
Monsanto Co
MON
+$2.36M
5
GE icon
GE Aerospace
GE
+$2.18M

Sector Composition

Rank Sector Weight
1 Healthcare 20.12%
2 Technology 17.36%
3 Financials 12.49%
4 Industrials 10.03%
5 Consumer Staples 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLB icon
151
State Street Materials Select Sector SPDR ETF
XLB
$8.55B
$426K 0.07%
15,000
– –
SIRI icon
152
SiriusXM
SIRI
$10.1B
$425K 0.07%
7,700
– –
USB icon
153
US Bancorp
USB
$99.4B
$412K 0.06%
2,672
-3,955
-60% -$207K
XLE icon
154
State Street Energy Select Sector SPDR ETF
XLE
$38.1B
$403K 0.06%
11,766
+1,400
+14% +$45.5K
TRV icon
155
Travelers Companies
TRV
$80.5B
$392K 0.06%
3,200
– –
CUZ icon
156
Cousins Properties
CUZ
$4.91B
$374K 0.06%
10,002
– –
IBB icon
157
iShares Biotechnology ETF
IBB
$9.53B
$371K 0.06%
+3,342
New +$357K
NVDA icon
158
NVIDIA
NVDA
$5.3T
$368K 0.06%
+82,400
New +$343K
XLK icon
159
State Street Technology Select Sector SPDR ETF
XLK
$122B
$350K 0.05%
11,844
+2,844
+32% +$81.9K
KERX
160
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$322K 0.05%
45,350
– –
DVY icon
161
iShares Select Dividend ETF
DVY
$23.5B
$310K 0.05%
3,305
+100
+3% +$9.25K
IMCB icon
162
iShares Morningstar Mid-Cap ETF
IMCB
$1.69B
$301K 0.05%
6,888
– –
CNI icon
163
Canadian National Railway
CNI
$76.5B
$292K 0.05%
3,524
– –
ALR
164
DELISTED
Alere Inc
ALR
$291K 0.05%
5,700
– –
XLV icon
165
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
$277K 0.04%
3,386
+16
+0.5% +$1.28K
FDX icon
166
FedEx
FDX
$74.7B
$263K 0.04%
1,165
– –
BXMX
167
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$262K 0.04%
18,766
+3,000
+19% +$41.6K
CMCSA icon
168
Comcast
CMCSA
$89.3B
$251K 0.04%
6,530
– –
NEE icon
169
NextEra Energy
NEE
$176B
$251K 0.04%
6,848
– –
MU icon
170
Micron Technology
MU
$996B
$250K 0.04%
+6,365
New +$201K
MDXG icon
171
MiMedx Group
MDXG
$609M
$249K 0.04%
+21,000
New +$311K
MDLZ icon
172
Mondelez International
MDLZ
$80.1B
$241K 0.04%
5,939
+1
+0% +$42
DE icon
173
Deere & Co
DE
$166B
$236K 0.04%
1,879
+5
+0.3% +$617
SIMO icon
174
Silicon Motion
SIMO
$9.07B
$235K 0.04%
4,900
– –
OMCL icon
175
Omnicell
OMCL
$1.64B
$231K 0.04%
+4,525
New +$217K
4 5 6
7
8

Similar funds

KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.52B AUM
ACL
Azora Capital LP Miami, Florida $1.52B AUM 39.16% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.52B AUM 56.21% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return

Marco Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Marco Investment Management held 189 positions worth $640M, up 5.8% from $605M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marco Investment Management's Q3 2017 filing shows 14 new, 70 increased, 56 reduced and 6 closed positions. Its largest new stake was Allergan plc: 17,274 shares worth $3.54M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Marco Investment Management's largest Q3 2017 buy was Allergan plc: 17,274 shares worth $3.54M.
  • Marco Investment Management added most to DuPont de Nemours in Q3 2017, an estimated $6.97M increase.
  • Marco Investment Management's biggest Q3 2017 reduction was Amgen, cutting an estimated $19.6M.
  • Marco Investment Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $6.73M.
  • Marco Investment Management's ten largest holdings make up 27% of its $640M portfolio in Q3 2017.
  • Marco Investment Management opened 14 new positions and closed 6 in Q3 2017.
  • Marco Investment Management's portfolio value rose 5.8% quarter-over-quarter to $640M.

Based on Marco Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.